Clinical Trial Update: Expanded Access to ABBV-706

View source ↗

Summary

An expanded access program for ABBV-706 in small cell lung cancer has been made available to eligible patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ABBV-706

Snippet

Sponsor: AbbVie | Conditions: Small Cell Lung Cancer | Status: AVAILABLE